Trial intelligence / Profile preview

Effect of pramipexole on tinnitus in presbycusis

2007-006271-37Phase 2Completed

Sponsor
University of Debrecen Department of Otolaryngology, Head and Neck Surgery
Start
Dec 2007
Countries
1
01

Overview

Phase 2, single-arm trial of Pramipexole or Ropinirole in tinnitus and presbycusis, sponsored by University of Debrecen Department of Otolaryngology, Head and Neck Surgery. Primary endpoints: Hearing outcome at 4 weeks and Hearing outcome at 12 weeks. Started Dec 2007; status: completed.

02

Drugs

Pramipexole or Ropinirole
03

Conditions

tinnituspresbycusis

Beyond the preview

Go deeper on 2007-006271-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006271-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call